Amylin as a Novel Diabetes and Obesity Therapy

Explore this recorded session focusing on obesity from the American Diabetes Association’s Scientific Sessions. This on-demand video highlights emerging research, evolving clinical guidance, therapeutic advances, and new perspectives on the physiology, assessment, and management of obesity.

Overview

Learning Objectives

Recognize the physiologic and therapeutic rationale for amylin-based approaches to obesity treatment.
Identify evidence regarding the efficacy, safety, and tolerability of amylin-based therapies.
Identify clinical and practical considerations relevant to the potential use of amylin-based therapies in obesity management.

Faculty

W. Timothy Garvey, MD, MACE, MABOM

Carel LeRoux, MD, PhD

Thomas Lutz, PhD

Summary

Availability:

On-Demand

Expires on Jan 01, 2028

Cost:

FREE

Credit Offered:

No Credit Offered

Create Account